4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-19-000111
Options or other derivatives
- CHIEF FINANCIAL OFFICER acquired 80,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| WEAVER GREGORY L CHIEF FINANCIAL OFFICER | 2019-01-30 | Grant or award · Stock Options | +60,000 | 60,000 | D: show line 1 in the form | ||
| WEAVER GREGORY L CHIEF FINANCIAL OFFICER | 2019-01-30 | Grant or award · Restricted Stock Units | +20,000 | 20,000 | D: show line 2 in the form |
Loading xslF345X03/form4-01312019_040123.xml…